Biology:MVC-COV1901
From HandWiki
Short description: Vaccine candidate against COVID-19
| Vaccine description | |
|---|---|
| Target disease | SARS-CoV-2 |
| Type | Protein subunit |
| Clinical data | |
| Routes of administration | Intramuscular |
| Identifiers | |
| DrugBank | |
MVC-COV1901 is a COVID-19 vaccine candidate developed by Medigen Vaccine Biologics in Taiwan.[1][2][3]
References
- ↑ "A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Adult (COVID-19)". United States National Library of Medicine. https://clinicaltrials.gov/ct2/show/NCT04695652.
- ↑ "A Study to Evaluate the Safety and Immunogenicity of MVC-COV1901 Against COVID-19". United States National Library of Medicine. https://clinicaltrials.gov/ct2/show/NCT04487210.
- ↑ "A Study to Evaluate MVC-COV1901 Vaccine Against COVID-19 in Elderly Adults". United States National Library of Medicine. https://clinicaltrials.gov/ct2/show/NCT04822025.
External links
 |
